It was found that p53 expression was elevated when S100A4 expression was enhanced, cyclin D1 was inhibited, and synthesis of the cyclin/CDK complex was blocked suggesting that AML tumor cells are blocked from entering S phase in G1 phase. Here, S100A4 is linked to acute myeloid leukemia.